We announced today new clinical data on our #bivalent Omicron-containing #booster, mRNA-1273.214. Read more: https://investors.modernatx.com/news/news-details/2022/90-Day-Analysis-Shows-Modernas-Omicron-BA.1-Targeting-Bivalent-Vaccine-mRNA-1273.214-Demonstrates-Superior-Antibody-Response-as-Fourth-Booster-Compared-to-Spikevax-Prototype-Booster/default.aspx…
Show this thread